Literature DB >> 20013659

XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia.

J P Meza-Espinoza1, V Peralta-Leal, M Gutierrez-Angulo, N Macias-Gomez, M L Ayala-Madrigal, P Barros-Nuñez, J Duran-Gonzalez, E Leal-Ugarte.   

Abstract

We examined the influence of the Arg194Trp, Arg280His, and Arg399Gln polymorphisms of XRCC1 (X-ray repair cross-complementing group 1) on the development of childhood acute lymphoblastic leukemia (ALL) in 120 ALL patients and 120 controls in Mexico. All of them were genotyped for these polymorphisms, using polymerase chain reaction. No significant differences in allele and genotype frequencies for any polymorphism were observed between patients and controls. Estimation of haplotypes showed the eight expected haplotypes (A-H), seven of which were found in both patients and controls; haplotype A (Arg-Arg-Arg) was the most common, whereas haplotypes F and G were absent in patients and controls, respectively. Haplotype B (Trp-Arg-Arg) was found to be associated with an increased risk of ALL (odds ratio (OR) = 1.95, 95% confidence interval (CI) = 1.13-3.37; P = 0.016), particularly in males (OR = 2.65, 95%CI = 1.25-5.63; P = 0.01). Individually, the 194Trp, 280His, and 399Gln alleles were not associated with significantly increased risk for ALL in these Mexican children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013659     DOI: 10.4238/vol8-4gmr687

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  15 in total

1.  DNA repair gene XRCC1 polymorphisms and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis.

Authors:  Juan Du; Cong Lu; Guohui Cui; Yan Chen; Jing He
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

2.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

3.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

4.  Study on the association between the Arg194Trp polymorphism in the XRCC1 gene and the risk of hematological malignancies.

Authors:  Lizhi Tang; Tianyuan Xiong; Qingyi Jia; Qing He; Xiang Tong; Yuanling Peng; Jiani Shen; Jiqiao Yang; Yonggang Zhang
Journal:  Tumour Biol       Date:  2014-01-12

Review 5.  Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk.

Authors:  B Karahalil; V A Bohr; D M Wilson
Journal:  Hum Exp Toxicol       Date:  2012-09-27       Impact factor: 2.903

6.  Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia.

Authors:  Pelin Mutlu; Mualla Pınar Elçi; Murat Yıldırım; Oral Nevruz; Ahmet Türker Çetin; Ferit Avcu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

7.  The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.

Authors:  Liang Du; Yuqi Liu; Pei Xue; Chenxi Song; Jiani Shen; Qing He; Yuanling Peng; Xiang Tong; Lizhi Tang; Yonggang Zhang
Journal:  Tumour Biol       Date:  2015-01-27

8.  The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies.

Authors:  Xiang Tong; Jiqiao Yang; Yuanling Peng; Jiani Shen; Tianyuan Xiong; Yonggang Zhang; Hong Fan
Journal:  Tumour Biol       Date:  2013-10-06

9.  Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.

Authors:  Hana Salimizand; Sabrieh Amini; Mohammad Abdi; Bayazid Ghaderi; Namam-Ali Azadi
Journal:  Tumour Biol       Date:  2015-08-07

10.  X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.

Authors:  Libing Wang; Fan Yin; Xia Xu; Xiaoxia Hu; Dongbao Zhao
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.